| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.7M | +94.1% |
| R&D Expense | $53.4M | -36.4% |
| SG&A Expense | $39.1M | -5.9% |
| Operating Income | -$43.7M | +56.4% |
| Interest Expense | $2.2M | +100.7% |
| Net Income | -$61.3M | +45.1% |
| EPS (Basic) | -$15.96 | -1156.7% |
| EPS (Diluted) | -$15.96 | -1156.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $116.7M | -38.5% |
| Accounts Receivable | $901K | +25.1% |
| Current Assets | $136.4M | -31.5% |
| Total Assets | $159.8M | -32.9% |
| Current Liabilities | $50.0M | -16.2% |
| Long-term Debt | $22.2M | +0.0% |
| Total Liabilities | $140.9M | -20.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.1M | -83.8% |
| Investing Cash Flow | $5.8M | +275.6% |
| Financing Cash Flow | $5.4M | -94.3% |
| Stockholders' Equity |
| $18.9M |
| -68.8% |